Several research articles recently published detail new and innovative drug solutions to fight mesothelioma. Scientists from around the world continue to develop potential solutions with Korea releasing their findings tied to a leukemia treatment and red wine. Published in Biochemistry and Molecular Biology, the study found clofarabine, a drug typically used with relapsed leukemia cases
Archive for the 'Cancer Monthly' Category
Developing mesothelioma after asbestos exposure is a known occurrence, yet little research is conducted to evaluate the risk period after first exposure. Scientists in Italy and Australia studied more than 20,000 people exposed to asbestos and more than 800 patients diagnosed with mesothelioma to determine the long-term risks. Based on participants, the median exposure length
For those with inoperable malignant pleural mesothelioma, Alimta (permetrexed) combined with cisplatin remains the top treatment. Japanese researchers recently analyzed the results of 30 patients taking either Gemzar or the Alimta combination and compared complications, disease control and survival rates. Thirty mesothelioma cases were examined featuring 13 patients taking Gemzar and the remaining 17 taking
A recent study by United Kingdom researchers discovered when considering the mesothelioma surgery options, there is no clear choice. Cancer centers and mesothelioma doctors often disagree about which procedure to offer between extrapleural pneumonectomy (EPP) and pleurectomy/decotication (P/D). The surgeries attempt to either remove and cure the patient or relieve the tumor-caused symptoms, including pain.
Petition Demands Congress to Totally Ban Asbestos in Industrial Materials, Consumer Products and Toys Please sign the petition to totally ban asbestos. 1989 asbestos ban overturned Scientists agree that asbestos causes cancer and other deadly diseases, that thousands of Americans die each year from asbestos-related diseases, and there's no known safe level of exposure to
How can a tiny mineral kill tens of thousands of people and cost industry billions of dollars? It’s actually pretty simple when the mineral is a carcinogen called asbestos and companies tried to hide its dangers. Diseases caused by asbestos include: mesothelioma, lung cancer, and asbestosis. The Surviving Mesothelioma website (http://www.survivingmesothelioma.com) has listed some of
Mesothelioma survivor, Paul Kraus recently delivered another outstanding presentation about how he healed his mesothelioma. Paul was “devoid of all hope” after he was given only a few months to live after his mesothelioma diagnosis in 1997. But, he did not give up. Instead, this ten-year mesothelioma survivor used integrative, holistic, and experimental therapies. Today,
This year, mesothelioma survivor Paul Kraus will mark the 10th year of his recovery from mesothelioma. In June 1997, Paul Kraus was diagnosed with mesothelioma and given only a few months to live. He and his family were stunned by the shocking diagnosis, but were not ready to give up. They researched different therapies for
Paul Kraus, a nine-year survivor of mesothelioma, recently delivered another inspiring presentation on how he healed his cancer. Every few months, Mr. Kraus presents his experience with mesothelioma and answers questions from newly diagnosed mesothelioma patients and their families. If you are a mesothelioma patient or a family member of a mesothelioma patient and wish
Paul Kraus delivered another inspiring presentation on how he healed his mesothelioma. Every two months, Paul Kraus describes his experience with mesothelioma and answers questions from newly diagnosed mesothelioma patients. If you are a mesothelioma patient or a loved one of a mesothelioma patient and wish to attend a free teleconference with mesothelioma survivor Paul
Mesothelioma patients can now speak directly to Paul Kraus, perhaps the world's longest living mesothelioma survivor. In 1997, Paul Kraus was diagnosed with mesothelioma. Because his disease was widely spread, his doctors told him that they could not cure him and that he should start putting his affairs in order. Instead of giving up, he
The Premier Edition of Cancer Monthly's CancerWire focuses on mesothelioma and how one patient has survived a terminal diagnosis. Like Cancer Monthly, the focus of CancerWire is on treatment results. While, Cancer Monthly reports the cancer treatments results published in the peer reviewed medical literature, CancerWire reports on results that have not yet enjoyed the
Cancer Monthly: created by volunteers who have lost loved ones to cancer, patients can compare clinical results (survival rates and side effects) of hundreds of different cancer therapies
January 5, 2005. In August 1998, two-year-old Alexander Horwin was diagnosed with medulloblastoma, a highly malignant brain tumor. Surgeons removed the entire tumor and in October 1998, Alexander was administered what the Horwins were told was “state-of-the-art” chemotherapy 1. Three months after starting this 12-month protocol and while he was receiving the drugs, Alexander died
Last update: March 06, 2014. 08:41:31 pm.